ABC
TAK icon

Associated Banc-Corp’s Takeda Pharmaceutical TAK Stock Holding History

Associated Banc-Corp’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-512
Closed -$9K – 808
2020
Q4 		$9K Sell
512
-200
-28% -$3.51K ﹤0.01% 449
2020
Q3 		$13K Buy
712
+68
+11% +$1.24K ﹤0.01% 412
2020
Q2 		$12K Sell
644
-62
-9% -$1.11K ﹤0.01% 403
2020
Q1 		$11K Buy
+706
New +$12.8K ﹤0.01% 392

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Associated Banc-Corp's TAK Position: Q1 2021 in Review

Associated Banc-Corp sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 512 shares — an estimated $9K sold.

Associated Banc-Corp first reported a position in TAK in Q1 2020 and held it in 4 quarters. The position peaked at $13K in Q3 2020. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • Associated Banc-Corp reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 512 Takeda Pharmaceutical shares in Q1 2021, an estimated $9K.
  • Associated Banc-Corp first reported a position in Takeda Pharmaceutical in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Takeda Pharmaceutical position peaked at $13K in Q3 2020.
  • 316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.